Elevated expression of indoleamine 2,3-dioxygenase (IDO) and accumulation of kynurenic acid in the pathogenesis of STZ-induced diabetic cataract in wistar rats

Current Eye Research

Volumn 34, Issue 4, 2009, Pages 274-281

  Kanth, Vangipurapu Rajani ^a   Lavanya, Katikala ^a   Srinivas, Jayanthi ^a   Naga Raju, Turlapati ^a  

^a OSMANIA UNIVERSITY   (India)

Author keywords

Diabetic cataract; IDO; INF ; Kynurenic acid; Oxidative stress; Tryptophan metabolism

Indexed keywords

ALDEHYDE REDUCTASE; CARBONYL DERIVATIVE; GAMMA INTERFERON; GLUTATHIONE; GLUTATHIONE PEROXIDASE; IDITOL DEHYDROGENASE; INDOLEAMINE 2,3 DIOXYGENASE; KYNURENIC ACID; LENS PROTEIN; MALONALDEHYDE; STREPTOZOCIN; SUPEROXIDE DISMUTASE; TRYPTOPHAN; MESSENGER RNA; OXIDOREDUCTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOMICROSCOPY; CATARACT; CATARACTOGENESIS; CONTROLLED STUDY; ENZYME ACTIVITY; HYPERGLYCEMIA; MALE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SLIT LAMP; ANIMAL; DOWN REGULATION; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; GENETICS; LENS; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME; WISTAR RAT;

ANIMALS; CATARACT; DIABETES MELLITUS, EXPERIMENTAL; DOWN-REGULATION; GLUTATHIONE; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON-GAMMA; KYNURENIC ACID; LENS, CRYSTALLINE; MALE; OXIDATIVE STRESS; OXIDOREDUCTASES; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TRYPTOPHAN;

EID: 67649637610     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.1080/02713680902725954     Document Type: Article

References (45)

1. Hegde KR, Varma SD. Combination of glycemic and oxidative stress in lens: Implications in augmentation of cataract formation in diabetes. Free Radical Res 2005;39(5):513-517.
2. Cotlier E, Sharma YR, Zuckerman J, Pucklin J, Teasley B, Irvine J. Plasma tryptophan in humans with diabetic and senile cataracts. Exp Eye Res 1981;33:247-252.
3. Zarnowski T, Rejdak R, Zielinska-Rzecka E, et al. Elevated concentrations of kynurenic acid, a tryptophan derivative, in dense nuclear cataracts. Curr Eye Res 2007;32:27-32.
4. Andrzejewska-Buczko J, Pawlak D, Tankiewicz A, et al. Possible involvement of kynurenamines in the pathogenesis of cataract in diabetic patients. Med Sci Monitor 2001;7:742-745.
5. SM Chung S, CM HO E, SL Lam K, Chung SK. Contribution of polyol pathway to diabetes-induced oxidative stress. J Am Soc Nephrol 2003;14:S233-S236.
6. Krishna CM, Uppuluri S, Riesz P, Zigler JS Jr, Balasubramanian D. A study of the photodynamic efficiencies of some eye lens constituents. Photochem Photobiol 1991;54(1):51-58.
7. Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products: A review. Diabetologia 2001;44(2):129-146.
8. Staniszewska MM, Nagaraj RH. 3-Hydroxykynurenine-mediated modification of human lens proteins. J Biol Chem 2005;280:22154-22164.
9. Brownlee M. Negative consequences of glycation. Metabolism 2000;49(2):9-13.
10. Ortwerth BJ, Prabhakaram M, Nagaraj RH, Linetsky M. The relative UV sensitizer activity of purified advanced glycation end products. Photochem Photobiol 1997;65(4):666-673.
11. Takikawa O, Littlejohn TK, Jamie JF, Walker JM, Truscott RJW. Regulation of indoleamine 2,3-dioxygenase, the first enzyme in UV filter biosynthesis in the human lens. In: Tryptophan, Serotonin and Melatonin: Basic Aspects and Applications. New York: Kluwer Academic; 1999:241-245.
12. Pfefferkorn ER. Interferon blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc Natl Acad Sci USA 1984;81:908-912.
13. Thomas SR, Stocker R. Redox reactions related to indoleamine 2,3-dioxygenase and tryptophan metabolism along the kynurenine pathway. Redox Rep 1999;4:199-220.
14. Bhopale GM. Development of a vaccine for toxoplasmosis: Current status. Microbes Infect 2003;5:457-462.
15. Munn DH, Zhou M, Attwood JT, et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998;28:1191-1193.
16. Heyes MP, Saito K, Lackner A, Wiley CA, Achim CL, Markey SP. Sources of the neurotoxin quinolinic acid in the brain of HIV-1-infected patients and retrovirus-infected macaques. FASEB J 1998;12:881-896.
17. Sanni LA, Thomas SR, Tattam BN, et al. Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria. Am J Pathol 1998;152:611-619.
18. Pawlak D, Tankiewicz A, Mysliwiec P, Buczko W. Tryptophan metabolism via the kynurenine pathway in experimental chronic renal failure.Nephron 2002;90:328-335.
19. Aquilina JA, Carver JA, Truscott RJW. Oxidation of products of 3-hydroxykynurenine bind to lens proteins: Relevance for nuclear cataract. Exp Eye Res 1997;64:727-735.
20. Malina HZ, Martin XD. Indoleamine 2,3-dioxygenase: Antioxi-dant enzyme in the human eye. Graefes Arch Clin Exp Ophthalmol 1996;234:457-462.
21. Serbecic N, Beutelspacher SC. Indoleamine 2,3-dioxygenase protects corneal endothelial cells from UV mediated damage. Exp Eye Res 2006;82:416-426.
22. Suryanarayana P, Saraswat M, Mrudula T, Krishna TP, Krishnaswamy K, Reddy GB. Curcumin and turmeric delay streptozotocin-induced diabetic cataract in rats. Invest Ophthal-mol Vis Sci 2005;46(6):2092-2099.
23. Bergmayer HU, Bernt E. Glucose determination with glucose oxidase and peroxidase. In: Bergmeyer HU, ed. Methods of Enzymatic Analysis. 2nd ed. New York: Academic Press; 1974:1205-1206.
24. Matin A, Streete IM, Jamie IM, Truscott RJW, Jamie JF. A fluorescence-based assay for indoleamine 2,3-dioxygenase. Anal Biochem 2006;349:96-102.
25. Herve C, Beyne P, Jamault H, Delacoux E. Determination of tryptophan and its kynurenine pathway metabolites in human serumbyhigh-performance liquid chromatography with simultaneous ultraviolet and fluorimetric detection. J Chromatogr B 1996;675:157-161.
26. Templar J, Kon SP, Milligan TP, Newman DJ, Raftery MJ. Increased plasma malondialdehyde levels in glomerular disease as determined by a fully validated HPLC method. Nephrol Dial Transplant 1999;14:946-951.
27. Uchida K, Kanematsu M, Sakai K, et al. Protein-bound acrolein: Potential markers for oxidative stress. Proc Natl Acad Sci USA 1998;95:4882-4887.
28. Hissin PJ, Hilf R. A fluorometric for determination of oxidized and reduced glutathione in tissues. Anal Biochem 1976;74:214-226.
29. Hayman S, Kinoshita JH. Isolation and properties of lens aldose reductase. J Biol Chem 1965;240:877-882.
30. GerlachU,HibyW.Sorbitol dehydrogenase. In: Bergmeyer HU, ed. Methods of Enzymatic Analysis, 2nd ed.New York: Academic Press; 1974:56-73.
31. Marklund S, Marklund G. Involvement of the superoxide anion radicalinthe autooxidationofpyrogallol anda convenient assay for superoxide dismutase. Eur J Biochem 1974;47:469-474.
32. Martinez JI, Launay JM, Dreux C. A sensitive fluorimetric microassay for the determination of glutathione peroxidase activity. Application to human blood platelets. Anal Biochem 1979;98:184.
33. Raju TN, Kanth VR, Reddy PUM, Srinivas J, Shobanaditya J. Influence of kynurenines in pathogenesis of cataract formation in tryptophan-deficient regimen in wistar rats. Indian J Exp Biol 2007;45:543-548.
34. Perry RE, Swamy MS, Abraham EC. Progressive changes in lens crystallin glycation and high-molecular weight aggregate formation leading to cataract development in streptozotocin-diabetic rats. Exp Eye Res 1987;44:269-282.
35. Kojima M. Regional enzymatic analysis of UV-B and streptozotocin induced diabetic cataract lens. Lens Eye Toxic Res 1990;7(3-4):547-561.
36. Maritim AC, Sanders RA, Watkins III JB. Diabetes, oxidative stress, and antioxidants: A review. J Biochem Mol Toxicol 2003;17:24-83.
37. Truscott RJW, McNulty R, Taylor L, Hood B, Aquilina JA, Takikawa O. Tryptophan metabolism, aging and cataract. Int Congr Series 2002;1233:185-190.
38. Takikawa O, Truscott RJW, Fukao M, Miwa S. Age-related nuclear cataract and indoleamine 2,3-dioxygenase-initiated tryptophan metabolism in the human lens. Adv Exp Med Biol 2003;527:277-285.
39. Parker NR, Jamie JF, Davies MJ, Truscott RJW. Protein-bound kynurenine is photosensitizer of oxidative damage. Free Rad Biol Med 2004;37:1479-1489.
40. Taylor LM, Aquilina JA, Jamie JF, Truscott RJW. Glutathione and NADH, but not ascorbate, protect the lens proteins from modification by UV filters. Exp Eye Res 2002b;74:503-511.
41. Streete IM, Jamie JF, Truscott RJ. Lenticular levels of amino acids and free UV filters differ significantly between normals and cataract patients. Invest Ophthalmol Vis Sci 2004;45:4091-4098.
42. Connick JH, Stone TW. The role of kynurenines in diabetes mellitus. Med Hypotheses 1985;18:371-376.
43. Zsizsik BK, Hardeland R. Formation of kynurenic acid and xanthurenic acid from kynurenine and 3-hydroxykynurenine in the dinoflagellatae Lingulodinum polyedrum: Role of a novel oxidative pathway. Comp Biochem Physiol C Toxicol Pharmacol 2002;133:383-392.
44. Taylor LM, Andrew Aquilina J, Jamie JF, Truscott RJ. UV filter instability: Consequences for the human lens. Exp Eye Res 2002;75:165-175.
45. Monnier VM, CeramiA.Nonenzymatic browning in vivo: Possible process for aging of long-lived proteins. Science 198;211:491-493.